These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2773422)

  • 1. [The use of anti-inflammatory agents and stimulators of reparative processes in myocardial infarction].
    Iabluchanskiĭ NI; Vlasenko MA; Kopitsa NI; Dykun IaV; Sokrut VN
    Vrach Delo; 1989 May; (5):22-5. PubMed ID: 2773422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of current anti-inflammatory agents on the reparative stage of inflammation].
    Nasyrov KhM; Lazareva DN
    Farmakol Toksikol; 1984; 47(1):84-8. PubMed ID: 6705906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of the duration of coronary occlusion on the healing of an experimental myocardial infarct].
    Syroïd DV; Sokrut VM; Shvyrenko IR
    Fiziol Zh (1994); 1999; 45(6):26-30. PubMed ID: 10687078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of reparative processes following experimental myocardial infarction.
    Gudbjarnason S; Fenton JC; Wolf PL; Bing RJ
    Arch Intern Med; 1966 Jul; 118(1):33-40. PubMed ID: 5940191
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of antioxidants and membrane protectors on clinical course and hemodynamics of patients with myocardial infarct].
    Dzizinskiĭ AA; Katiubin VP
    Ross Med Zh; 1992; (1):32-4. PubMed ID: 1535252
    [No Abstract]   [Full Text] [Related]  

  • 7. High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction.
    Adamek A; Hu K; Bayer B; Wagner H; Ertl G; Bauersachs J; Frantz S
    Basic Res Cardiol; 2007 Jul; 102(4):334-40. PubMed ID: 17340057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of reactivity disorders on the healing process in myocardial infarction].
    Iabluchanskiĭ NI; Sokrut VN
    Patol Fiziol Eksp Ter; 1990; (6):20-2. PubMed ID: 2082253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alteration of the microcirculation of the bulbar conjunctiva in patients with myocardial infarction during treatment with non-steroidal anti-inflammatory agents].
    Pilipenko VV; Iabluchanskiĭ NI
    Sov Med; 1983; (5):105-7. PubMed ID: 6612450
    [No Abstract]   [Full Text] [Related]  

  • 10. [The expediency of optimizing lipid peroxidation in treating complicated forms of myocardial infarct healing].
    Sokrut VN; Iabluchanskiĭ NI; Zhdaniuk IuI; Libman TIa
    Vrach Delo; 1990 Dec; (12):16-9. PubMed ID: 2089790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indomethacin and celecoxib impair rotator cuff tendon-to-bone healing.
    Cohen DB; Kawamura S; Ehteshami JR; Rodeo SA
    Am J Sports Med; 2006 Mar; 34(3):362-9. PubMed ID: 16210573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-steroidal anti-inflammatory agents and the heart].
    Mulczyk M; Kostecka-Pokryszko A
    Wiad Lek; 1986 Jul; 39(14):961-4. PubMed ID: 3538666
    [No Abstract]   [Full Text] [Related]  

  • 13. [The diagnosis and reparative processes in a protracted course of myocardial infarct].
    Movshovich BL; Barmotin GV
    Vrach Delo; 1989 Sep; (9):12-4. PubMed ID: 2609607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Exogenous phosphocreatine in the prevention and treatment of cardiac insufficiency in patients with myocardial infarction].
    Perepech NB; Nedoshivin AO; Kutuzova AE
    Klin Med (Mosk); 1993 Jan; 71(1):19-22. PubMed ID: 8046897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parenteral ketorolac and risk of myocardial infarction.
    Kimmel SE; Berlin JA; Kinman JL; Hennessy S; Feldman H; Carson JL; Strom BL
    Pharmacoepidemiol Drug Saf; 2002 Mar; 11(2):113-9. PubMed ID: 11998535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Idioventricular rhythm in patients with acute myocardial infarction: an indicator of perfusion or ischemic symptom].
    Negrusz-Kawecka M; Gajek J
    Pol Merkur Lekarski; 2000 Feb; 8(44):80-3. PubMed ID: 10808735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prophylactic use of Neoton in cardiac failure in patients with myocardial infarction].
    Perepech NB; Nedoshivin AO; Kutuzova A'E
    Klin Med (Mosk); 1997; 75(10):52-4. PubMed ID: 9490342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of myocardial infarction in the very elderly--impact of clinical effectiveness on practice.
    Qureshi AM; McDonald L; Primrose WR
    Scott Med J; 2000 Dec; 45(6):180-2. PubMed ID: 11216310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Late ventricular potentials and autonomic cardiac rhythm regulation in patients with acute myocardial infarction].
    Barbarash OL; Berns SA; Tarasov NI; Guliaeva EN; Anikin BS
    Klin Med (Mosk); 1997; 75(11):37-40. PubMed ID: 9490355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
    Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
    Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.